Quarterly report pursuant to Section 13 or 15(d)

Accrued expenses and other liabilities (Details)

v3.20.2
Accrued expenses and other liabilities (Details) - USD ($)
Sep. 30, 2020
Dec. 31, 2019
Accrued expenses and other liabilities.    
Accrued clinical trial expenses $ 627,604 $ 1,156,618
Compensation and related benefits 186,363 303,870
Other expenses 689,932 215,979
Accrued expenses $ 1,503,899 $ 1,676,467